- Motley Fool•2 days ago
These biotechs are poised to surge higher in the years ahead.
- GlobeNewswire•2 days ago
Amarin Corporation CEO, John Thero, to Chair the American Heart Association’s Heart & Stroke Ball in New York City
NEW YORK, BEDMINSTER, N.J., and DUBLIN, Ireland, March 21, 2017-- The American Heart Association and American Stroke Association announced today that John Thero will serve as chairman of its annual Heart ...
- GlobeNewswire•7 days ago
Amarin Reaches the Onset of Approximately 80% of the Target Aggregate Number of Primary Major Adverse Cardiovascular Events Within the REDUCE-IT Study
BEDMINSTER, N.J., and DUBLIN, Ireland, March 16, 2017-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...
AMRN : Summary for Amarin Corporation plc - Yahoo Finance
Amarin Corporation plc (AMRN)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||2.84 x 1000|
|Ask||3.27 x 10000|
|Day's Range||3.15 - 3.24|
|52 Week Range||2.56 - 3.65|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-7.76|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|